New insights into binding of natural chalcones to Bcl-2, Bcl-xL and Mcl-1 anti-apoptotic proteins

被引:0
作者
cirin, Dejan [1 ]
Krstonosic, Veljko [1 ]
机构
[1] Univ Novi Sad, Fac Med, Dept Pharm, Hajduk Veljkova 3, Novi Sad 21000, Serbia
关键词
natural chalcones; Bcl-2; proteins; BH3-binding groove; docking study; MM-GBSA; molecular dynamics; MULTIDRUG-RESISTANCE; ACCURATE PREDICTION; FLAVOKAWAIN B; CANCER CELLS; INHIBITORS; DYNAMICS; DOCKING; NAVITOCLAX; ANTITUMOR; LEUKEMIA;
D O I
10.1016/j.molstruc.2021.130700
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Knowledge about mechanisms responsible for induction of tumor cell apoptosis is important for the development of anticancer drugs. Mounting evidence suggests that the inhibition of anti-apoptotic proteins of Bcl-2 family is important part of antitumor activity of natural chalcones. In order to gain insights into their binding affinity and binding mechanism, the MM-GBSA binding energies were determined for 63 natural chalcones to Bcl-2, Bcl-xL and Mcl-1, by employing multiple crystal structures of each antiapoptotic protein. It was noticed that the chalcones have high affinity to the BH3-binding groove. The driving forces behind the binding and the anchor points on the proteins were determined for the top ranked chalcones, whereas the 30 0-ns Molecular Dynamics (MD) simulations provided more insights into the binding in the most stable complexes. The importance of ring A, ring B and the side chains of the chalcones for the interactions with the hydrophobic cavities of anti-apoptotic proteins was noticed. Although the natural compounds showed mainly favorable pharmacokinetic properties, some limitations in binding to the proteins, compared to the synthetic ligands, were noticed. This pointed out towards possible future directions of chemical modifications of the most potent natural compounds. It is envisioned that the results of this study could be useful for the selection of lead antitumor natural compounds as well as for the design of new synthetic BH3-mimetics. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:15
相关论文
共 56 条
  • [1] In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice
    Abu, Nadiah
    Mohamed, Nurul Elyani
    Yeap, Swee Keong
    Lim, Kian Lam
    Akhtar, M. Nadeem
    Zulfadli, Aimi Jamil
    Kee, Beh Boon
    Abdullah, Mohd Puad
    Omar, Abdul Rahman
    Alitheen, Noorjahan Banu
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1401 - 1417
  • [2] The BCL-2 arbiters of apoptosis and their growing role as cancer targets
    Adams, Jerry M.
    Cory, Suzanne
    [J]. CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) : 27 - 36
  • [3] Targeting cancer's Achilles' heel: role of BCL-2 inhibitors in cellular senescence and apoptosis
    Anantram, Aarti
    Degani, Mariam
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (17) : 2287 - 2312
  • [4] From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
    Ashkenazi, Avi
    Fairbrother, Wayne J.
    Leverson, Joel D.
    Souers, Andrew J.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (04) : 273 - 284
  • [5] Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
    Birkinshaw, Richard W.
    Gong, Jia-nan
    Luo, Cindy S.
    Lio, Daisy
    White, Christine A.
    Anderson, Mary Ann
    Blombery, Piers
    Lessene, Guillaume
    Majewski, Ian J.
    Thijssen, Rachel
    Roberts, Andrew W.
    Huang, David C. S.
    Colman, Peter M.
    Czabotar, Peter E.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [6] Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
    Boyd, Ben J.
    Bergstrom, Christel A. S.
    Vinarov, Zahari
    Kuentz, Martin
    Brouwers, Joachim
    Augustijns, Patrick
    Brandl, Martin
    Bernkop-Schnuerch, Andreas
    Shrestha, Neha
    Preat, Veronique
    Mullertz, Anette
    Bauer-Brandl, Annette
    Jannin, Vincent
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 137
  • [7] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
    Bruncko, Milan
    Oost, Thorsten K.
    Belli, Barbara A.
    Ding, Hong
    Joseph, Mary K.
    Kunzer, Aaron
    Martineau, Darlene
    McClellan, William J.
    Mitten, Michael
    ng, Shi-Chu Ng
    Nimmer, Paul M.
    Oltersdorf, Tilman
    Park, Cheol-Min
    Petros, Andrew M.
    Shoemaker, Alexander R.
    Song, Xiaohong
    Wang, Xilu
    Wendt, Michael D.
    Zhang, Haichao
    Fesik, Stephen W.
    Rosenberg, Saul H.
    Elmore, Steven W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 641 - 662
  • [8] Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest
    Buso Bortolotto, Luis Felipe
    Barbosa, Flavia Regina
    Silva, Gabriel
    Bitencourt, Tamires Aparecida
    Beleboni, Rene Oliveira
    Baek, Seung Joon
    Marins, Mozart
    Fachin, Ana Lucia
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 425 - 433
  • [9] Casara Patrick, 2018, Oncotarget, V9, P20075, DOI 10.18632/oncotarget.24744
  • [10] The antibacterial activities of aditoprim and its efficacy in the treatment of swine streptococcosis
    Cheng, Guyue
    Xu, Yamei
    Zhu, Xudong
    Xie, Shuyu
    Wang, Liye
    Huang, Lingli
    Hao, Haihong
    Liu, Zhenli
    Pan, Yuanhu
    Chen, Dongmei
    Wang, Yulian
    Yuan, Zonghui
    [J]. SCIENTIFIC REPORTS, 2017, 7